De Lorenzo F, Rubba P, Monticelli A, Cocozza S
Institute of Internal Medicine and Metabolic Diseases, 2nd Medical School University of Naples, Italy.
Angiology. 1993 Oct;44(10):785-90. doi: 10.1177/000331979304401004.
The possible associations between coronary heart disease (CHD) and peripheral arterial disease (PAD), detected by echo-Doppler analysis, with restriction fragment length polymorphism (RFLP) of apo AI/CIII cluster and apo B gene were investigated in a group of men with premature CHD (n = 39) and in a control group of men without evidence of CHD (n = 40). The genetic analysis of SstI RFLP of apo AI/CIII cluster showed a significantly higher frequency of the rare SstI allele (S2) in CHD patients (0.16) as compared with controls (0.06). No significant differences were found in the frequencies of XbaI RFLP for the apo B gene between CHD patients and controls. Moreover, patients with PAD showed no significant differences in the frequencies of XbaI RFLP for the apo B gene and of SstI RFLP for the apo AI/CIII cluster as compared with patients without evidence of peripheral arterial disease detected by echo-Doppler analysis.
通过超声多普勒分析检测到的冠心病(CHD)与外周动脉疾病(PAD)之间的可能关联,以及载脂蛋白AI/CIII簇和载脂蛋白B基因的限制性片段长度多态性(RFLP),在一组早发性冠心病男性患者(n = 39)和一组无冠心病证据的男性对照组(n = 40)中进行了研究。载脂蛋白AI/CIII簇的SstI RFLP基因分析显示,冠心病患者中罕见的SstI等位基因(S2)频率(0.16)显著高于对照组(0.06)。冠心病患者和对照组之间载脂蛋白B基因的XbaI RFLP频率未发现显著差异。此外,与经超声多普勒分析未检测到外周动脉疾病证据的患者相比,患有PAD的患者在载脂蛋白B基因的XbaI RFLP频率和载脂蛋白AI/CIII簇的SstI RFLP频率上未发现显著差异。